Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

Miao Wang,1,* Jin Shi,2,* Kepei Zhang,1,* Jie Hong,2,* Xinwei Peng,2 Yu Tian,1 Wei Lu,3 Ke Li,2 Zengliang Wang,4 Feng Li,1 Zhijie Zhang,2 Guojiang Mei1 1Department of Internal Medicine of Traditional Chinese Medicine, Longhua Hospital, Shanghai University of Tradition...

Full description

Bibliographic Details
Main Authors: Wang M, Shi J, Zhang K, Hong J, Peng X, Tian Y, Lu W, Li K, Wang Z, Li F, Zhang Z, Mei G
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Infection and Drug Resistance
Subjects:
covid-19
omicron variant
traditional chinese medicine
prospective study
Online Access:https://www.dovepress.com/efficacy-and-safety-of-longyizhengqi-granule-in-treatment-of-mild-covi-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/efficacy-and-safety-of-longyizhengqi-granule-in-treatment-of-mild-covi-peer-reviewed-fulltext-article-IDR

Similar Items